Betta Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 2/6
Betta Pharmaceuticals is a dividend paying company with a current yield of 0.31% that is well covered by earnings.
Key information
0.3%
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 0.3% |
| Future Dividend Yield | 1.0% |
| Dividend Growth | 2.3% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.170 |
| Payout ratio | 16% |
Recent dividend and buyback updates
Recent updates
Is Now The Time To Put Betta Pharmaceuticals (SZSE:300558) On Your Watchlist?
Dec 17
Does Betta Pharmaceuticals (SZSE:300558) Have A Healthy Balance Sheet?
Nov 26We Think That There Are Some Issues For Betta Pharmaceuticals (SZSE:300558) Beyond Its Promising Earnings
Nov 04Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Still On The Mark Following 29% Share Price Bounce
Sep 30Results: Betta Pharmaceuticals Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates
Aug 07Unpleasant Surprises Could Be In Store For Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) Shares
Jul 30These 4 Measures Indicate That Betta Pharmaceuticals (SZSE:300558) Is Using Debt Reasonably Well
Jul 05Betta Pharmaceuticals' (SZSE:300558) Earnings Are Weaker Than They Seem
Apr 26Earnings Miss: Betta Pharmaceuticals Co., Ltd. Missed EPS By 6.1% And Analysts Are Revising Their Forecasts
Apr 23What Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Not Telling You
Apr 16Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300558 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 300558 has only been paying a dividend for 8 years, and since then payments have fallen.
Dividend Yield vs Market
| Betta Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300558) | 0.3% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Pharmaceuticals) | 1.8% |
| Analyst forecast (300558) (up to 3 years) | 1.0% |
Notable Dividend: 300558's dividend (0.31%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.54%).
High Dividend: 300558's dividend (0.31%) is low compared to the top 25% of dividend payers in the CN market (2.09%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (15.5%), 300558's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (22.9%), 300558's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 04:58 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Betta Pharmaceuticals Co., Ltd. is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yue Gao | Changjiang Securities Co. LTD. |
| Jin Zhang | China International Capital Corporation Limited |
| Jing Qiang | China International Capital Corporation Limited |